Xibrom Combination Therapy With Lucentis Successful

Armen Hareyan's picture
Advertisement

Calvin A. Grant, MD, Retina Macular Care, presented the results from his 60-patient retrospective case control study that was designed to evaluate the adjuvant use of Xibrom (bromfenac ophthalmic solution) 0.09% in Lucentis (ranibizumab) treatment of choroidal neovascularization secondary to age-related macular degeneration (AMD) in an oral poster presentation at the 2008 Annual Meeting of the Association for Research in Vision and Ophthalmology (ARVO).

Advertisement